Acarbose
Alpha-glucosidase inhibitor in USP/EP/BP grade for oral tablet formulation manufacturing. Sourced for post-prandial hyperglycaemia management in Type 2 diabetes product lines.
Pharmaceutical & Life Science Solutions
Biguanides, sulfonylureas, thiazolidinediones, and alpha-glucosidase inhibitors for glycaemic control. Supplied in USP/EP/BP/IP grade for oral solid-dose manufacturing across Type 2 diabetes product lines.
Alpha-glucosidase inhibitor in USP/EP/BP grade for oral tablet formulation manufacturing. Sourced for post-prandial hyperglycaemia management in Type 2 diabetes product lines.
Lipid-soluble synthetic derivative of vitamin B1 in USP/EP/JP/BP grade for tablet and nutraceutical formulation manufacturing. Sourced for diabetic neuropathy adjunct and metabolic supplement product lines.
Second-generation sulfonylurea in BP/EP/USP/IP grade for oral tablet formulation manufacturing. Sourced for Type 2 diabetes insulin secretagogue product lines.
Sulfonylurea with antithrombotic properties in BP/EP grade for oral tablet formulation manufacturing. Sourced for Type 2 diabetes and cardiovascular-protective formulation lines.
Third-generation sulfonylurea in USP/EP/BP/IP grade (micronized forms available) for oral tablet formulation manufacturing. Sourced for once-daily Type 2 diabetes management product lines.
Second-generation sulfonylurea in USP/EP grade for oral tablet formulation manufacturing, including extended-release variants. Sourced for Type 2 diabetes glycaemic control product lines.
First-line biguanide antidiabetic supplied as hydrochloride salt — USP/EP/BP grade — for oral tablet and extended-release formulation manufacturing. Sourced for Type 2 diabetes insulin sensitisation product lines.
PPAR-gamma agonist thiazolidinedione supplied as hydrochloride salt — USP/EP grade — for oral tablet formulation manufacturing. Sourced for Type 2 diabetes insulin sensitisation product lines.